• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过规避内源性控制蛋白的调节作用,利用兔红细胞激活替代补体途径。

Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.

作者信息

Fearon D T, Austen K F

出版信息

J Exp Med. 1977 Jul 1;146(1):22-33. doi: 10.1084/jem.146.1.22.

DOI:10.1084/jem.146.1.22
PMID:559720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2180739/
Abstract

Cleavage of C3 by the alternative complement pathway occurs in at least two distinct phases: continuous low grade generation of C3b by the interaction of native C3, B, D, and P, and subsequent amplified cleavage of C3 by the interaction of C3b, B, D, and P which forms the amplification convertase, P,C3b,Bb. Transition to C3b-dependent amplification is necessary to achieve substantial C3 cleavage and is normally limited by the combined action of C3b inactivator (C3bINA) and betalH. An activator of the alternative pathway, such as rabbit erythrocytes (E(r)), provides sites that protect bound C3b and P,C3b,Bb from the action of these regulatory proteins and permits C3b deposited by the low grade fluid phase reaction to assemble a membrane-associated amplification convertase which can deposit additional protected C3b. Under conditions in which the control proteins, C3bINA and beta1H, almost completely inactivated C3b bound to sheep erythrocytes (E(s)), which does not activate the alternative pathway, the function of C3b bound to E(r) was diminished by less than one-fifth. Further, the P- stabilized amplification convertase on E(r) was 10-fold less sensitive to beta1H-mediated decay-dissociation than the convertase on E(s). The addition of E(r) to a regulated mixture of purified C3, B, D, P, C3bINA, and beta1H resulted in amplified inactivation of C3 and B by formation of the amplification convertase on E(r) as indicated by its lysis with subsequent exposure to C3-C9. In contrast, E(s) did not advance the low grade fluid phase inactivation of C3 and B to amplified inactivation and the cell was not converted to an intermediate susceptible to lysis by C3- C9. Since E(r) and E(s) did not differ in their inefficient fixation of C3b generated during an unregulated fluid phase reaction, the activating capacity of E(r) must reside in its protection of bound C3b and P, C3b,Bb from the regulatory proteins rather than in enhanced capacity to bind C3b from the fluid phase. When the reaction is limited to low grade fluid phase turnover, introduction of E(r) but not E(s) results in a 100-fold increase in the deposition of C3b, indicating that surface-dependent activation of the alternative pathway is characterized by efficient deposition of C3b on the initiating surface. Thus, the activating surfaces advance the interaction of the alternative pathway proteins to the amplification phase because of the selective inability of the regulatory proteins to deal with their substrates when deposited on these surfaces and results in a specificity that is not necessarily dependent on adaptive immunity.

摘要

补体替代途径对C3的裂解至少发生在两个不同阶段:天然C3、B、D和P相互作用持续产生低水平的C3b,随后C3b、B、D和P相互作用对C3进行扩增裂解,形成扩增转化酶P、C3b、Bb。向依赖C3b的扩增转变对于实现大量C3裂解是必要的,且通常受C3b灭活因子(C3bINA)和β1H的联合作用限制。替代途径的激活剂,如兔红细胞(E(r)),提供了保护结合的C3b和P、C3b、Bb免受这些调节蛋白作用的位点,并允许低水平液相反应沉积的C3b组装膜相关的扩增转化酶,该转化酶可沉积额外的受保护C3b。在控制蛋白C3bINA和β1H几乎完全灭活与绵羊红细胞(E(s))结合的C3b(E(s)不激活替代途径)的条件下,与E(r)结合的C3b的功能降低不到五分之一。此外,E(r)上的P稳定扩增转化酶对β1H介导的衰变解离的敏感性比E(s)上的转化酶低10倍。将E(r)添加到纯化的C3、B、D、P、C3bINA和β1H的受调节混合物中,由于E(r)上形成了扩增转化酶,导致C3和B通过随后暴露于C3 - C9而裂解,从而使C3和B的失活得到扩增。相比之下,E(s)没有将C3和B的低水平液相失活推进到扩增失活,并且该细胞没有转化为对C3 - C9裂解敏感的中间体。由于E(r)和E(s)在无调节的液相反应中产生的C3b固定效率方面没有差异,E(r)的激活能力必定在于其保护结合的C3b和P、C3b、Bb免受调节蛋白的作用,而不是在于增强从液相中结合C3b的能力。当反应限于低水平液相周转时,引入E(r)而非E(s)会导致C3b沉积增加100倍,这表明替代途径的表面依赖性激活的特征是C3b在起始表面上的有效沉积。因此,激活表面将替代途径蛋白的相互作用推进到扩增阶段,因为当调节蛋白沉积在这些表面上时,它们选择性地无法处理其底物,从而产生一种不一定依赖于适应性免疫的特异性。

相似文献

1
Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.通过规避内源性控制蛋白的调节作用,利用兔红细胞激活替代补体途径。
J Exp Med. 1977 Jul 1;146(1):22-33. doi: 10.1084/jem.146.1.22.
2
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.由于酵母聚糖结合的扩增转化酶对内源调节机制具有抗性,导致替代补体途径激活。
Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7. doi: 10.1073/pnas.74.4.1683.
3
Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.补体C3转化酶:β1H调控的细胞表面限制及神经氨酸酶处理细胞上限制的产生
Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20. doi: 10.1073/pnas.75.5.2416.
4
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.膜增生性肾小球肾炎和同种异体移植排斥反应中补体激活途径。
Transplant Proc. 1977 Mar;9(1):729-39.
5
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.补体替代途径:不稳定的C3/C5转化酶招募前体备解素并增强该途径。
J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076.
6
A molecular basis of activation of the alternative pathway of human complement.人类补体替代途径激活的分子基础。
Adv Exp Med Biol. 1979;120B:3-17.
7
Control of the amplification convertase of complement by the plasma protein beta1H.血浆蛋白β1H对补体扩增转化酶的调控
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72. doi: 10.1073/pnas.73.9.3268.
8
Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.从人红细胞膜分离出的一种抑制性蛋白对人补体C3转化酶扩增的调节作用。
Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71. doi: 10.1073/pnas.76.11.5867.
9
Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.膜唾液酸对替代补体途径中C3转化酶β1H依赖性衰变解离的调节作用。
Proc Natl Acad Sci U S A. 1978 Apr;75(4):1971-5. doi: 10.1073/pnas.75.4.1971.
10
The natural modulation of the amplification phase of complement activation.补体激活放大阶段的自然调节
Transplant Rev. 1976;32:12-25. doi: 10.1111/j.1600-065x.1976.tb00226.x.

引用本文的文献

1
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex.CD59保护原代人脑血管平滑肌细胞免受溶细胞性膜攻击复合物的损伤。
Brain Sci. 2024 Jun 14;14(6):601. doi: 10.3390/brainsci14060601.
2
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex.CD59保护原代人脑血管平滑肌细胞免受溶细胞性膜攻击复合物的损伤。
Res Sq. 2024 Apr 1:rs.3.rs-4165045. doi: 10.21203/rs.3.rs-4165045/v1.
3
Quantification of Factor H Mediated Self vs. Non-self Discrimination by Mathematical Modeling.通过数学建模对因子 H 介导的自身与非自身识别进行定量分析。
Front Immunol. 2020 Sep 2;11:1911. doi: 10.3389/fimmu.2020.01911. eCollection 2020.
4
Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease.建模补体旁路途径的激活及其在健康和疾病中对溶血的影响。
PLoS Comput Biol. 2020 Oct 2;16(10):e1008139. doi: 10.1371/journal.pcbi.1008139. eCollection 2020 Oct.
5
Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.金黄色葡萄球菌毒素 LukSF 与其膜受体靶标解离,从而能够重新隔离配体。
FASEB J. 2019 Mar;33(3):3807-3824. doi: 10.1096/fj.201801910R. Epub 2018 Dec 3.
6
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径:C3 和 C5 激活的“替代激活途径”还是“关键扩增环”?
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
7
Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.葡萄球菌蛋白Ecb会损害补体受体1介导的对调理素化细菌的识别。
PLoS One. 2017 Mar 8;12(3):e0172675. doi: 10.1371/journal.pone.0172675. eCollection 2017.
8
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.补体因子H与内皮细胞的结合是由羧基末端糖胺聚糖结合位点介导的。
Am J Pathol. 2005 Oct;167(4):1173-81. doi: 10.1016/S0002-9440(10)61205-9.
9
Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.当C3b与新型隐球菌荚膜结合时,C3b加速降解为iC3b。
Infect Immun. 1993 Oct;61(10):4360-6. doi: 10.1128/iai.61.10.4360-4366.1993.
10
Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.正常人类免疫球蛋白G对镰状细胞病患者血清中针对肺炎链球菌的调理作用缺陷的恢复。
Infect Immun. 1981 Aug;33(2):636-40. doi: 10.1128/iai.33.2.636-640.1981.

本文引用的文献

1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
An alternative mechanism for the properdin system.备解素系统的另一种机制。
J Exp Med. 1958 Oct 1;108(4):515-35. doi: 10.1084/jem.108.4.515.
3
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
4
Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.豚鼠和兔血清中补体成分的三种天然存在的抑制剂。
J Immunol. 1967 Sep;99(3):582-9.
5
A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.超敏反应和移植免疫中免疫抑制的新概念。
Surv Ophthalmol. 1966 Aug;11(4):498-505.
6
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定分子量的可靠性。
J Biol Chem. 1969 Aug 25;244(16):4406-12.
7
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.人血清中“胶固素激活因子”的证实及其对补体第三成分的作用。
J Immunol. 1968 Apr;100(4):691-8.
8
C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.人C3b灭活因子。II. 细胞结合型或液相C3b经C3b灭活因子裂解产生的片段
J Immunol. 1971 Sep;107(3):742-50.
9
Properdin factor D: characterization of its active site and isolation of the precursor form.备解素因子D:其活性位点的表征及前体形式的分离。
J Exp Med. 1974 Feb 1;139(2):355-66. doi: 10.1084/jem.139.2.355.
10
The role of properdin in the alternate pathway of complement activation.备解素在补体激活替代途径中的作用。
J Exp Med. 1974 Jan 1;139(1):44-57. doi: 10.1084/jem.139.1.44.